Ciprofloxacin Use for Helicobacter pylori Eradication
Ciprofloxacin has been studied as a component of H. pylori eradication regimens, including ciprofloxacin-based triple therapy combined with a proton-pump inhibitor and another antibiotic. [1, 2]
Recommended Regimen Considerations
Standard H. pylori eradication regimens use proton-pump inhibitor–based multidrug therapy rather than ciprofloxacin alone. [3]
Evidence Supporting Ciprofloxacin-Based Regimens
A randomized study in Iranian children compared a ciprofloxacin-containing regimen (ciprofloxacin, amoxicillin, and omeprazole) with furazolidone-based triple therapy and reported higher eradication 1 month after treatment end (87.9% vs 60.6%). [1]
A randomized controlled trial in children (ages 3 to 16 years) compared several eradication regimens and reported an eradication rate of 90% with ciprofloxacin-based triple therapy. [2]
Evidence Limitations
Ciprofloxacin-based eradication regimens are supported mainly by small studies in children rather than by high-quality adult guideline-level evidence. [1, 2]
Real-World Use of Non-Preferred Antibiotics
Population data from Sweden identified ciprofloxacin as one of the antibiotics used in some H. pylori eradication episodes that did not follow the recommended regimen (2.4% among “other prescribed antibiotics”). [3]
Clinical Implication
Ciprofloxacin can eradicate H. pylori when incorporated into a multidrug regimen with a proton-pump inhibitor and additional antibiotics, but it is not supported as a preferred regimen choice based on the available evidence base. [1, 2, 3]